Relevance of motoneuron specification and programmed cell death in embryos to therapy of ALS

Birth Defects Research Part C - Embryo Today: Reviews

Volumn 75, Issue 4, 2005, Pages 294-304

  Banks, Glen B ^a   Chamberlain, Jeffrey S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Amyotrophic lateral sclerosis; Gene therapy; Motor neuron survival; Programmed cell death; Stem cell

Indexed keywords

ANTIOXIDANT; CARDIOTROPHIN 1; COPPER ZINC SUPEROXIDE DISMUTASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN RECEPTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SOMATOMEDIN C; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CELL SURVIVAL; DRUG MECHANISM; EMBRYO DEVELOPMENT; GENE MUTATION; HUMAN; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; SPINAL CORD MOTONEURON; STEM CELL TRANSPLANTATION; VIRAL GENE THERAPY; VIRUS PARTICLE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOPTOSIS; CELL DIFFERENTIATION; EMBRYO; EMBRYONIC DEVELOPMENT; GENE THERAPY; HUMANS; MOTOR NEURONS;

ANIMALIA;

EID: 32644443605     PISSN: 1542975X     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdrc.20051     Document Type: Review

References (113)

1. Acsadi G, Anguelov RA, Yang H, et al. 2002. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy. Hum Gene Ther 13:1047-1059.
2. Afonso ND, Catala M. 2005. Sonic hedgehog and retinoic acid are not sufficient to induce motoneuron generation in the avian caudal neural tube. Dev Biol 279:356-367.
3. Arakawa Y, Sendtner M, Thoenen H. 1990. Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines. J Neurosci 10:3507-3515.
4. Azzouz M, Mazarakis N. 2004. Non-primate EIAV-based lentiviral vectors as gene delivery system for motor neuron diseases. Curr Gene Ther 4:277-286.
5. Azzouz M, Ralph GS, Storkebaum E, et al. 2004. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429:413-417.
6. Bain G, Kitchens D, Yao M, et al. 1995. Embryonic stem cells express neuronal properties in vitro. Dev Biol 168:342-357.
7. Banks GB, Chau TN, Bartlett SE, Noakes PG. 2001. Promotion of motoneuron survival and branching in rapsyn-deficient mice. J Comp Neurol 429:156-165.
8. Banks GB, Noakes PG. 2002. Elucidating the molecular mechanisms that underlie the target control of motoneuron death. Int J Dev Biol 46:551-558.
9. Banks GB, Choy PT, Lavidis NA, Noakes PG. 2003a. Neuromuscular synapses mediate motoraxon branching and motoneuron survival during the embryonic period of programmed cell death. Dev Biol 257:71-84.
10. Banks GB, Fuhrer C, Adams ME, Froehner SC. 2003b. The postsynaptic submembrane machinery at the neuromuscular junction: requirement for rapsyn and the utrophin/dystrophin-associated complex. J Neurocytol 32:709-726.
11. Banks GB, Kanjhan R, Wiese S, et al. 2005. Glycinergic and GABAergic synaptic activity differentially regulate motoneuron survival and skeletal muscle innervation. J Neurosci 25:1249-1259.
12. Bendotti C, Carri MT. 2004. Lessons from models of SOD1-linked familial ALS. Trends Mol Med 10:393-400.
13. Borchelt DR, Lee MK, Slunt HS, et al. 1994. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci U S A 91:8292-8296.
14. Bordet T, Lesbordes JC, Rouhani S, et al. 2001. Protective effects of cardiotrophin-1 adenoviral gene transferon neuromuscular degeneration in transgenic ALS mice. Hum Mol Genet 10:1925-1933.
15. Brandon EP, Lin W, D'Amour KA, et al. 2003. Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice. J Neurosci 23:539-549.
16. Bruijn LI, Miller TM, Cleveland DW. 2004. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27:723-749.
17. Buss RR, Oppenheim RW. 2004. Role of programmed cell death in normal neuronal development and function. Anat Sci Int 79:191-197.
18. Chen R, Ende N. 2000. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J Med 31:21-30.
19. Chen J, Butowt R, Rind HB, von Bartheld CS. 2003. GDNF increases the survival of developing oculomotor neurons through a target-derived mechanism. Mol Cell Neurosci 24:41-56.
20. Clement AM, Nguyen MD, Roberts EA, et al. 2003. Wile-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302:113-117.
21. Corti S, Locatelli F, Donadoni C, et al. 2004. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 127:2518-2532.
22. Dahm LM, Landmesser LT. 1988. The regulation of intramuscular nerve branching during normal development and following activity blockade. Dev Biol 130:621-644.
23. Dahm LM, Landmesser LT. 1991. The regulation of synaptogenesis during normal development and following activity blockade. J Neurosci 11:238-255.
24. Dasen JS, Liu JP, Jessell TM. 2003. Motor neuron columnar fate imposed by sequential phases of Hox-c activity. Nature 425:926-933.
25. D'Costa AP, Prevette DM, Houenou LJ, et al. 1998. Mechanisms of insulin-like growth factor regulation of programmed cell death of developing avian motoneurons. J Neurobiol 36:379-394.
26. DeChiara TM, Bowen DC, Valenzuela DM, et al. 1996. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85:501-512.
27. de la Rosa EJ, de Pablo F. 2000. Cell death in early neural development: beyond the neurotrophic theory. Trends Neurosci 23:454-458.
28. Dobrowolny G, Giacinti C, Pelosi L, et al. 2005. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 168:193-199.
29. Eisen JS, Melancon E. 2001. Interactions with identified muscle cells break motoneuron equivalence in embryonic zebrafish. Nat Neurosci 4:1065-1070.
30. Ende N, Weinstein F, Chen R, Ende M. 2000. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci 67:53-59.
31. Feng G, Mellor RH, Bernstein M, et al. 2000. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41-51.
32. Forger NG, Prevette D, deLapeyriere O, et al. 2003. Cardiotrophin-like cytokine/cytokine-like factor 1 is an essential trophic factor for lumbar and facial motoneurons in vivo. J Neurosci 23:8854-8858.
33. Garbuzova-Davis S, Willing AE, Zigova T, et al. 2003. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res 12:255-270.
34. Gautam M, Noakes PG, Mudd J, et al. 1995. Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 377:232-236.
35. Gautam M, Noakes PG, Moscoso L, et al. 1996. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85:525-535.
36. Ghadge GD, Wang L, Sharma K, et al. 2005. Truncated wild-type SOD1 and FALS-linked mutant SOD1 cause neural cell death in the chick embryo spinal cord. Neurobiol Dis. In press.
37. Gong YH, Parsadanian AS, Andreeva A, et al. 2000. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J Neurosci 20:660-665.
38. Gould TW, Burek MJ, Ishihara R, et al. 1999. Androgens rescue avian embryonic lumbar spinal motoneurons from injury-induced but not naturally occurring cell death. J Neurobiol 41:585-595.
39. Gould TW, Oppenheim RW. 2004. The function of neurotrophic factor receptors expressed by the developing adductor motor pool in vivo. J Neurosci 24:4668-4682.
40. Gregorevic P, Blankinship MJ, Allen JM, et al. 2004. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10:828-834.
41. Grieshammer U, Lewandoski M, Prevette D, et al. 1998. Muscle-specific cell ablation conditional upon Cre-mediated DNA recombination in transgenic mice leads to massive spinal and cranial motoneuron loss. Dev Biol 197:234-247.
42. Grothe C, Unsicker K. 1992. Basic fibroblast growth factor in the hypoglossal system: specific retrograde transport, trophic, and lesion-related responses. J Neurosci Res 32:317-328.
43. Gubitz AK, Feng W, Dreyfuss G. 2004. The SMN complex. Exp Cell Res 296:51-56.
44. Guillot S, Azzouz M, Deglon N, et al. 2004. Local GDNF expression mediated by lentiviral vector protects facial nerve motoneurons but not spinal motoneurons in SOD1(G93A) transgenic mice. Neurobiol Dis 16:139-149.
45. Guthrie S. 2002. Neuronal development: sorting out motor neurons. Curr Biol 12:R488-R490.
46. Habgood MD, Hopkins WG, Slack JR. 1984. Muscle size and motor unit survival in mice. J Physiol 356:303-314.
47. Hamburger V. 1934. The effects of wing bud extirpation in chick embryos on the development of the central nervous system. J Exp Zool 68:449-494.
48. Harris AJ, McCaig CD. 1984. Motoneuron death and motor unit size during embryonic development of the rat. J Neurosci 4:13-24.
49. Henderson CE, Yamamoto Y, Livet J, et al. 1998. Role of neurotrophic factors in motoneuron development. J Physiol Paris 92:279-281.
50. Houenou LJ, Pincon-Raymond M, Garcia L, et al. 1990. Neuromuscular development following tetrodotoxin-induced inactivity in mouse embryos. J Neurobiol 21:1249-1261.
51. Howland DS, Liu J, She Y, et al. 2002. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A 99:1604-1609.
52. Jessell TM. 2000. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat Rev Genet 1:20-29.
53. Kaspar BK, Llado J, Sherkat N, et al. 2003. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301:839-842.
54. Kaspar BK, Frost LM, Christian L, et al. 2005. Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann Neurol 57:649-655.
55. Keller-Peck CR, Feng G, Sanes JR, et al. 2001. Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction. J Neurosci 21:6136-6146.
56. Klein SM, Behrstock S, McHugh J, et al. 2005. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther 16:509-521.
57. Lambrechts D, Storkebaum E, Morimoto M, et al. 2003. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383-394.
58. Landmesser L, Dahm L, Schultz K, Rutishauser U. 1988. Distinct roles for adhesion molecules during innervation of embryonic chick muscle. Dev Biol 130:645-670.
59. Landmesser L, Dahm L, Tang JC, Rutishauser U. 1990. Polysialic acid as a regulator of intramuscular nerve branching during embryonic development. Neuron 4:655-667.
60. Landmesser L. 1992. The relationship of intramuscular nerve branching and synaptogenesis to motoneuron survival. J Neurobiol 23:1131-1139.
61. Lee SK, Pfaff SL. 2001. Transcriptional networks regulating neuronal identity in the developing spinal cord. Nat Neurosci 4(Suppl):1183-1191.
62. Leitner ML, Molliver DC, Osborne PA, et al. 1999. Analysis of the retrograde transport of glial cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests that in vivo signaling for the GDNF family is GFRalpha coreceptor-specific. J Neurosci 19:9322-9331.
63. Lin W, Burgess RW, Dominguez B, et al. 2001. Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse. Nature 410:1057-1064.
64. Lino MM, Schneider C, Caroni P. 2002. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 22:4825-4832.
65. Liu J, Lillo C, Jonsson PA, et al. 2004. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43:5-17.
66. Lu YY, Wang U, Muramatsu S, et al. 2003. Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport. Neurosci Res 45:33-40.
67. Martinov VN, Sefland I, Walaas SI, et al. 2002. Targeting functional subtypes of spinal motoneurons and skeletal muscle fibers in vivo by intramuscular injection of adenoviral and adeno-associated viral vectors. Anat Embryol (Berl) 205:215-221.
68. Mazzini L, Fagioli F, Boccaletti R, et al. 2003. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 4:158-161.
69. McLennan IS. 1982. Size of motoneuron pool maybe related to number of myotubes in developing muscle. Dev Biol 92:263-265.
70. McLennan IS. 1988. Quantitative relationships between motoneuron and muscle development in Xenopus laevis: implications for motoneuron cell death and motor unit formation. J Comp Neurol 271:19-29.
71. Miles GB, Yohn DC, Wichterle H, et al. 2004. Functional properties of motoneurons derived from mouse embryonic stem cells. J Neurosci 24:7848-7858.
72. Mohajeri MH, Figlewicz DA, Bohn MC. 1999. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum Gene Ther 10:1853-1866.
73. Nagai M, Aoki M, Miyoshi I, et al. 2001. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci 21:9246-9254.
74. Oosthuyse B, Moons L, Storkebaum E, et al. 2001. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 28:131-138.
75. Oppenheim RW, Nunez R. 1982. Electrical stimulation of hindlimb increases neuronal cell death in chick embryo. Nature 295:57-59.
76. Oppenheim RW, Houenou L, Pincon-Raymond M, et al. 1986. The development of motoneurons in the embryonic spinal cord of the mouse mutant, muscular dysgenesis (mdg/mdg): survival, morphology, and biochemical differentiation. Dev Biol 114:426-436.
77. Oppenheim RW. 1991. Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501.
78. Oppenheim RW, Houenou LJ, Johnson JE, et al. 1995. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373:344-346.
79. Oppenheim RW, Prevette D, Houenou LJ, et al. 1997. Neuromuscular development in the avian paralytic mutant crooked neck dwarf (cn/cn): further evidence for the role of neuromuscular activity in motoneuron survival. J Comp Neurol 381:353-372.
80. Oppenheim RW, Homma S, Marti E, et al. 1999. Modulation of early but not later stages of programmed cell death in embryonic avian spinal cord by sonic hedgehog. Mol Cell Neurosci 13:348-361.
81. Oppenheim RW, Houenou LJ, Parsadanian AS, et al. 2000a. Glial cell line-derived neurotrophic factor and developing mammalian motoneurons: regulation of programmed cell death among motoneuron subtypes. J Neurosci 20:5001-5011.
82. Oppenheim RW, Prevette D, D'Costa A, et al. 2000b. Reduction of neuromuscular activity is required for the rescue of motoneurons from naturally occurring cell death by nicotinic-blocking agents. J Neurosci 20:6117-6124.
83. Oppenheim RW, Caldero J, Cuitat D, et al. 2003. Rescue of developing spinal motoneurons from programmed cell death by the GABA(A) agonist muscimol acts by blockade of neuromuscular activity and increased intramuscular nerve branching. Mol Cell Neurosci 22:331-343.
84. Pasinelli P, Belford ME, Lennon N, et al. 2004. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43:19-30.
85. Pittman RH, Oppenheim RW. 1978. Neuromuscular blockade increases motoneurone survival during normal cell death in the chick embryo. Nature 271:364-366.
86. Pittman R, Oppenheim RW. 1979. Cell death of motoneurons in the chick embryo spinal cord. IV. Evidence that a functional neuromuscular interaction is involved in the regulation of naturally occurring cell death and the stabilization of synapses. J Comp Neurol 187:425-446.
87. Pramatarova A, Laganiere J, Roussel J, et al. 2001. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 21:3369-3374.
88. Price SR, De Marco Garcia NV, Ranscht B, Jessell TM. 2002. Regulation of motor neuron pool sorting by differential expression of type II cadherins. Cell 109:205-216.
89. Rabizadeh S, Gralla EB, Borchelt DR, et al. 1995. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an anti-apoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci U S A 92:3024-3028.
90. Ralph GS, Radcliffe PA, Day DM, et al. 2005. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat Med 11:429-433.
91. Raoul C, Abbas-Terki T, Bensadoun JC, et al. 2005. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med 11:423-428.
92. Reaume AG, Elliott JL, Hoffman EK, et al. 1996. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43-47.
93. Riethmacher D, Sonnenberg-Riethmacher E, Brinkmann V, et al. 1997. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 389:725-730.
94. Rind HB, von Bartheld CS. 2002. Target-derived cardiotrophin-1 and insulin-like growth factor-I promote neurite growth and survival of developing oculomotor neurons. Mol Cell Neurosci 19:58-71.
95. Rind HB, Butowt R, von Bartheld CS. 2005. Synaptic targeting of retrogradely transported trophic factors in motoneurons: comparison of glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, and cardiotrophin-1 with tetanus toxin. J Neurosci 25:539-549.
96. Sanes JR, Lichtman JW. 2001. Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat Rev Neurosci 2:791-805.
97. Sejvar JJ, Holman RC, Bresee JS, et al. 2005. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology 25:144-152.
98. Selverstone Valentine J, Doucette PA, Zittin Potter S. 2005. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74:563-593.
99. Sendtner M, Pei G, Beck M, et al. 2000. Developmental motoneuron cell death and neurotrophic factors. Cell Tissue Res 301:71-84.
100. Shorey M. 1909. The effect of the destruction of peripheral areas on the differentiation of the neuroblast. J Exp Zool 7:25-64.
101. Silani V, Leigh N. 2003. Stem therapy for ALS: hope and reality. Amyotroph Lateral Scler Other Motor Neuron Disord 4:8-10.
102. Silani V, Cova L, Corbo M, et al. 2004. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet 364:200-202.
103. Strong MJ, Kesavapany S, Pant HC. 2005. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J Neuropathol Exp Neurol 64:649-664.
104. Tanaka H, Landmesser LT. 1986. Cell death of lumbosacral motoneurons in chick, quail, and chick-quail chimera embryos: a test of the quantitative matching hypothesis of neuronal cell death. J Neurosci 6:2889-2899.
105. Tang J, Landmesser L. 1993. Reduction of intramuscular nerve branching and synaptogenesis is correlated with decreased motoneuron survival. J Neurosci 13:3095-3103.
106. Terrado J, Burgess RW, DeChiara T, et al. 2001. Motoneuron survival is enhanced in the absence of neuromuscular junction formation in embryos. J Neurosci 21:3144-3150.
107. Usiak MF, Landmesser LT. 1999. Neuromuscular activity blockade induced by muscimol and d-tubocuracine differentially affects the survival of embryonic chick motoneurons. J Neurosci 19:7925-7939.
108. Wang U, Lu YY, Muramatsu S, et al. 2002. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci 22:6920-6928.
109. Wang J, Xu G, Slunt HH, et al. 2005. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol Dis. 20:943-952.
110. Wichterle H, Lieberam I, Porter JA, Jessell TM. 2002. Directed differentiation of embryonic stem cells into motor neurons. Cell 110:385-397.
111. Yaginuma H, Tomita M, Takashita N, et al. 1996. A novel type of programmed neuronal death in the cervical spinal cord of the chick embryo. J Neurosci 16:3685-3703.
112. Yamamoto Y, Henderson CE. 1999. Patterns of programmed cell death in populations of developing spinal motoneurons in chicken, mouse, and rat. Dev Biol 214:60-71.
113. Yan Q, Elliott JL, Matheson C, et al. 1993. Influences of neurotrophins on mammalian motoneurons in vivo. J Neurobiol 24:1555-1577.